Objective: Bee (Apis mellifera L.) venom (BV) has been used as a cosmetic ingredient owing to its anti-aging, anti-inflammatory, and antibacterial effects. The aim of this study was to assess the skin safety of BV.
| INTRODUCTION
The bee venom (BV) from honeybees (Apis mellifera L.) has long been used as a complementary medicine to treat an array of conditions. 1, 2 Pure BV is generally obtained by electric stunning using a BV collector without harming the honeybees. Impurities are then removed from the collected BV, which is subsequently lyophilized to give the final product. BV comprises a number of bioactive substances such as melittin, apamin, adolapin, and mast cell degranulating peptide. 3 In recent years, it has been used as a cosmetic ingredient in antiphotoaging and anti-acne products. 4 In a previous study, we
showed that BV exerts skin photoprotective activity through reduction of the protein levels of matrix metalloproteinases, which are the main contributors to photoaging processes. 5 In another study, we
showed that BV used in the cosmetic industry as an antiwrinkle agent improves skin wrinkles. 6 BV effectively improved total wrinkle count and total wrinkle area in subjects with photodamaged skin.
Determination of irritant effects on skin and eyes is an important initial step in the assessment and evaluation of the safety of a substance. In this regard, it has been demonstrated that BV does not
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induce skin sensitization in guinea pigs and has no dermal or ocular irritation potential in New Zealand white rabbits. 7, 8 To assess the potential of BV for external application and topical uses, photosensitivity and phototoxicity tests were performed in this study. Photosensitivity is a broad term used to describe the unwanted phototoxic reactions of pharmaceuticals, pigments, and food additives to nonionizing radiations. 9 13 In the present study, the in vivo effects of BV were evaluated by performing photosensitivity and phototoxicity tests using animal models. Various acute toxicity test parameters were measured and compared with established values to ascertain whether BV has the potential to be used for topical dermatologic application without damaging the skin.
| MATERIALS AND METHODS

| BV gels
Purified bee venom (PBV TM ) added to the BV gel was obtained from colonies of natural honeybees. BV was collected using a bee venom collector (Chungjin Biotech, Korea) in a sterile manner and purified under strict laboratory conditions. Briefly, the collected venom was diluted in cold sterile water and centrifuged at 10 0009 g for 5 minutes at 4°C.
Residues in the supernatant were discarded. PBV TM was lyophilized and refrigerated at 4°C for later use. The BV gel was prepared using materials approved by the MFDS and formulated by following the instructions of the manufacturer (Dong Sung Pharmaceutical Co., Ltd. Seoul, Korea). BV gel containing 0.06% BV was formulated for use in this study. 
| Chemicals
| Skin phototoxicity test
Animals were divided into three groups (n=5) ( Table 1 judged by the Draize method at 24, 48, and 72 hours after irradiation. 15 Scores for erythema and edema formation for each treatment group were totaled for all animals at each observation time ( Table 2 ).
The totaled scores were divided by the number of animals employed in the study to obtain the mean scores (Table 3) . A site was concluded to be positive for phototoxicity when the score for the irradiated site was higher than that for the nonirradiated site. The average score was calculated by adding the scores for edema formation according to the primary skin irritation index as shown in Table 2 . 16 
| Skin photosensitivity test
Animals (20) were divided into three groups as shown in Table 4 .
The nuchal area (492 cm) was shaved and either 0.1 mL of BV gel, sterile water for injection, or TBS was applied evenly. After (305-420 nm). Subsequently, the application site was washed with sterile water for injection. The sensitization treatment was performed every 3rd day for 9 days (1 time/d). Twenty days to 4 weeks following the last sensitization exposure, the guinea pigs were challenged. The depilated lumbar area, which has two squares of 1.591.5 cm/site, was allocated as shown in Figure 2A . Each concentration (0.02 mL) was applied to the symmetrical sites on the left and right sides of the animal. The right of the back skin was covered with a sheet of aluminum foil (nonirradiated part) and the left of the back skin was UV-irradiated at 9 J/cm 2 (UVA, 305-420 nm) (Figure 2B ). After irradiation, the application sites were washed with sterile water for injection. The skin reactions at 24, 48, and 72 h after challenge were scored according to the scheme shown in Table 2 . The positivity values and their mean scores were calculated.
T A B L E 1 Experimental group assignment for the skin phototoxicity test in guinea pigs
The total scores for the dermal reactions induced by each compound were calculated and divided by the number of animals in that group to obtain the mean score for dermal reaction in each group. 17 The number of animals with positive skin reactions (1-4 points) was divided by the total number of animals and the positivity rate was obtained for each compound in each group. Photosensitization was judged collectively based on differences in the mean scores for skin reaction and positivity between the control and test groups (Table 5) . 3 | RESULTS
| Phototoxicity to BV gels
In the phototoxicity test, BV gel application to the guinea pigs caused no mortality or noticeable clinical signs throughout the study period (Table 6) . No body weight changes were observed in the BV gel-treated group (Figure 3) . Results of the phototoxicity study are shown in Table 7 and Appendix A1. In the negative control (G1) and BV gel (G2) groups, no skin reactions were detected in any animal at either irradiated sites or nonirradiated sites at any observation time.
In the positive control group (G3, 8-MOPS), no skin reactions were detected at the nonirradiated sites in any animal; however, formation of pronounced (grade 2) and strong (grade 3) erythema, and slightto-mild (grade 1) and pronounced edema were observed at the L R and edema were observed in the positive control, but not in the negative control and BV gel groups (Figure 4 ).
| Skin photosensitization study
No abnormal clinical signs were observed in any animal during the experimental period (Table 8 ). There was, however, a slight increase in the body weights of the BV gel group (G5) compared to the negative (G4) and positive (G6) control (3,5,4'-tribromosalicylanilide; TBS) groups ( Figure 5 ). Throughout the observation period, normal body weight gain was observed in every animal. Results of the skin reaction after challenge are shown in Table 9 and Appendix A2. No skin reaction was found in any animal in the negative control and BV gel groups; the positivity rate was 0%. At 24 hours after UVA irradiation, erythema was observed in all animals at the irradiated side in the positive control group; the mean positive index was 1.2, and the positivity rate was 100% (Figure 6 ). At 48 hours after irradiation, erythema was observed in four animals; the mean positive index was 1.0, and the positivity rate was 80%. At 72 hours after irradiation, erythema was observed in two animals; the mean positive index was 0.8, and the positivity rate was 40%. No skin reaction was observed in the nonirradiated side (R) at any observation time. | e71
| DISCUSSION
BV was developed for reducing acne formation associated with the inflammatory process. 4 The anti-acne effects of BV-containing serum have been investigated in humans. BV is a good candidate for development as a therapeutic modality for the treatment of acne vulgaris.
Long-term treatment of acne with BV could be safe, as its dermal irritation potential is negligible. 19 The EU Research Project CAESAR developed robust QSARs for five toxicological endpoints of regulatory importance, including skin sensitization. 20 A skin sensitizer is a substance that induces an allergic response following skin contact.
Substances are classified as skin sensitizers if there is evidence that the substance can induce sensitization upon skin contact in a substantial number of persons, or when there are positive results from an appropriate animal test. 20 The assessment and evaluation of phototoxicity and photosensitivity of potential drugs are important initial tests. 19 Therefore, the aim of the present study was to determine the phototoxicity and photosensitivity of BV in guinea pigs to ensure that its topical dermatologic use does not damage the skin. Skin phototoxicity is a type of irritation reaction attributable to the tissue injury induced by photo-activated compounds. 21 In the present study, no skin phototoxicity was induced by gel containing BV, sug- In this study, BV gel did not induce any obvious skin sensitization reaction.
In conclusion, BV application to guinea pigs caused no toxic effects on body weight, other clinical signs, or mortality. Further, in neither the skin phototoxicity nor the skin photosensitization study did it evoke a skin reaction. Recently, BV has been reported to possess an antibacterial effect against acne-inducing bacteria and on wound healing. 4, 23 Therefore, it is timely and appropriate to study the toxicological adverse effects of BV with the intent of developing it for topical medical application to the skin.
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